Valuation: DocMorris AG

Market Cap 479M 593M 513M 440M 827M 56.45B 840M 5.62B 2.21B 28.29B 2.23B 2.18B 93.54B P/E 2026 *
-6.05x
P/E 2027 * -12.1x
Enterprise Value 679M 841M 727M 623M 1.17B 80.03B 1.19B 7.97B 3.13B 40.11B 3.16B 3.09B 133B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.51x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 593M
-0.66%-1.17%-26.25%-25.76% 15.83B
+2.14%-0.28%-27.38%-34.91% 7.38B
+1.63%-1.78%-26.11%-8.35% 6.21B
-1.42%-2.55%-7.44%-33.05% 3.98B
-0.16%-0.99%-23.04%-37.55% 3.3B
-1.19%-2.06%-41.84%-24.45% 3.12B
-2.23%-7.11%-0.45%-39.83% 2.95B
+11.05%+10.88%+119.48% - 2.78B
0.00%-3.88%-14.65%+6.69% 2.62B
Average +0.92%-0.33%-5.30%-24.65% 5.35B
Weighted average by Cap. +0.61%-0.73%-15.03%-25.31%

Financials

2026 *2027 *
Net sales 1.24B 1.53B 1.32B 1.13B 2.13B 146B 2.17B 14.51B 5.7B 73.04B 5.75B 5.62B 241B 1.39B 1.72B 1.49B 1.27B 2.4B 164B 2.43B 16.3B 6.4B 82.02B 6.46B 6.32B 271B
Net income -81.01M -100M -86.75M -74.31M -140M -9.54B -142M -950M -373M -4.78B -377M -368M -15.81B -43.68M -54.07M -46.77M -40.07M -75.36M -5.15B -76.56M -512M -201M -2.58B -203M -199M -8.53B
Net Debt 200M 248M 214M 184M 345M 23.57B 351M 2.35B 921M 11.82B 930M 910M 39.06B 236M 292M 253M 216M 407M 27.8B 414M 2.77B 1.09B 13.93B 1.1B 1.07B 46.07B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
9.490CHF
Average target price
10.22CHF
Spread / Average Target
+7.68%

Quarterly revenue - Rate of surprise